Göm menyn

Publications for Eva Knaust

Co-author map based on Web of Sciences articles 2007-

Journal Articles

Eva Knaust, Anna Porwit-MacDonald, Astrid Gruber, Dawei Xu and Curt Peterson
  Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML
  Leukemia research: a Forum for Studies on Leukemia and Normal Hemopoiesis, 2003, 27(2), 183-191.
 Web of Science® Times Cited: 2

Kourosh Lotfi, Emma Månsson, Joya Chandra, Yuyinh Wang, Dawei Xu, Eva Knaust, Tanja Spasokoukotskaja, Eva Liliemark, Staffan Eriksson and Freidoun Albertioni
  Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide
  British Journal of Haematology, 2001, 113(2), 339-346.
 Web of Science® Times Cited: 29

Eva Knaust, Anna Porwit-MacDonald, Astrid Gruber, Dawei Xu and Curt Peterson
  Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin
  Haematologica, 2000, 85(2), 124-132.
 Web of Science® Times Cited: 12

Karolina A. Palucka, Eva Knaust, Xawei Dawei, Barbara Macnamara, Anna Portwit-Macdonald, Astrid Gruber, Curt Peterson, Magnus Björkholm and Pavel Pisa
  Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia
  Leukemia and Lymphoma, 1999, 32(3-4), 309-316.

D. Xu, Eva Knaust, P. Pisa, K. Palucka, J. Lundeberg, I. Areström, C. Peterson and A. Gruber
  Levels of mdr1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation
  British Journal of Haematology, 1996, 92(4), 847-854.

Ph.D. Theses

Eva Knaust
  Experimental studies on multidrug resistance in human leukaemia: role of cellular heterogeneity for daunorubicin kinetics

Licentiate Theses

Eva Knaust
  Heterogeneity of leukemic cells with regard to daunorubicin accumulation and efflux: potential role in drug resistance


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21